Showing 1 - 2 results of 2 for search 'Anna Maria Langkilde', query time: 0.01s Refine Results
  1. 1
    WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY

    WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY by Hiddo J.L. Heerspink, David C. Wheeler, Ricardo Correa-Rotter, Jamie P. Dwyer, Anna Maria Langkilde, Patrick B. Mark, Michal Nowicki, Peter Rossing, Robert D. Toto, Glenn M. Chertow, Niels Jongs

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

    Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial by Mohammad Abdel Jawad, Remo H. M. Furtado, Russell Esterline, Jan Oscarsson, Samvel B. Gasparyan, Gary G. Koch, Felipe Martinez, Omar Mukhtar, Subodh Verma, Anna Maria Langkilde, Philip Ambery, Shachi Patel, Kensey Gosch, Sheryl L. Windsor, Ronaldo V. P. Soares, Diogo D. F. Moia, Matthew Aboudara, Ali Javaheri, J. F. Kerr Saraiva, Lilia Nigro Maia, Otavio Berwanger, Andrew J. Sauer, Mikhail N. Kosiborod

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: